GERMAINE JACQUETTE, M.D.; PENELOPE H. DENNEHY, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In their review of the use of trimethoprim-sulfamethoxazole in the treatment of bacterial meningitis, Levitz and Quintiliani (1) conclude that it may play a major role in treatment of resistant gram-negative and Staphylococcus aureus meningitides. They also cite two reports of successful use of the drug in Listeria monocytogenes meningitis. We report our experience and note additional cases in the literature indicating that trimethoprim-sulfamethoxazole should be considered in the treatment of Listeria meningitis in appropriate situations.
A 73-year-old man with a history of resected renal cell Carcinoma, prostatectomy, recurrent urinary tract infections, and mild renal insufficiency was
JACQUETTE G, DENNEHY PH. Trimethoprim-Sulfamethoxazole in Listeria monocytogenes Meningitis. Ann Intern Med. ;102:866–867. doi: 10.7326/0003-4819-102-6-866_2
Download citation file:
Published: Ann Intern Med. 1985;102(6):866-867.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use